Stockbrokers

Hansa Biopharma to host conference call to provide interim results for first half 2021 and Business Update

Retrieved on: 
Thursday, July 1, 2021

LUND, Sweden, July 1, 2021 /PRNewswire/ -- Hansa Biopharma AB (Nasdaq Stockholm: HNSA) will publish its interim report for January-June 2021 at 8:00 CET on July 15, 2021.

Key Points: 
  • LUND, Sweden, July 1, 2021 /PRNewswire/ -- Hansa Biopharma AB (Nasdaq Stockholm: HNSA) will publish its interim report for January-June 2021 at 8:00 CET on July 15, 2021.
  • All interested parties are invited to participate in a telephone conference, which will include a presentation of the interim results and a business update, on the same date at 14:00 CET/8:00am EST.
  • The event will be hosted by Hansa Biopharma's CEO, Sren Tulstrup, and CFO, Donato Spota, and the presentation will be held in English.
  • Link to presentation
    To participate in the telephone conference, please use the dial-in details provided below:
    July 15, 2021 William Blair Biotech Focus Conference, 2021 (virtual)
    Aug 25, 2021 Handelsbanken Life Science Innovation Seminar, Stockholm
    Aug 31, 2021 Presentation at Penser Access, Skne
    Nov 25, 2021 Erik Penser Banks Bolagsdag, Stockholm or virtual

Infofree Offers 100 Free Business Leads for Wealth Management Professionals and Stockbrokers to Assist with Post-Pandemic Recovery

Retrieved on: 
Tuesday, June 22, 2021

OMAHA, Neb., June 22, 2021 /PRNewswire/ --Infofree, a leading provider of high-quality sales and business leads in the United States, today announced, for a limited time, an exclusive offer of 100 free business leads for wealth management professionals and stockbrokers during the months of July and August.

Key Points: 
  • OMAHA, Neb., June 22, 2021 /PRNewswire/ --Infofree, a leading provider of high-quality sales and business leads in the United States, today announced, for a limited time, an exclusive offer of 100 free business leads for wealth management professionals and stockbrokers during the months of July and August.
  • Now, we want to do the same for those in the wealth management and stockbroking industry."
  • This ensures wealth management professionals and stockbrokers can take advantage of a steady new business pipeline, with little wasted time on contacting leads that aren't viable.
  • For more information, or to claim the special offer of 100 free leads please visit www.infofree.com/100free , call (877) 448-0101, or email [email protected] .

Infofree Offers 100 Free Business Leads for Wealth Management Professionals and Stockbrokers to Assist with Post-Pandemic Recovery

Retrieved on: 
Friday, June 18, 2021

OMAHA, Neb., June 18, 2021 /PRNewswire/ --Infofree, a leading provider of high-quality sales and business leads in the United States, today announced, for a limited time, an exclusive offer of 100 free business leads for wealth management professionals and stockbrokers during the months of July and August.

Key Points: 
  • OMAHA, Neb., June 18, 2021 /PRNewswire/ --Infofree, a leading provider of high-quality sales and business leads in the United States, today announced, for a limited time, an exclusive offer of 100 free business leads for wealth management professionals and stockbrokers during the months of July and August.
  • Now, we want to do the same for those in the wealth management and stockbroking industry."
  • This ensures wealth management professionals and stockbrokers can take advantage of a steady new business pipeline, with little wasted time on contacting leads that aren't viable.
  • For more information, or to claim the special offer of 100 free leads please visit www.infofree.com/get100 , call (877) 448-0101, or email [email protected] .

ZINZINO AB (PUBL): PRELIMINARY SALES REPORT MAY 2021

Retrieved on: 
Thursday, June 3, 2021

Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25700, zinzino.com

Key Points: 
  • Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25700, zinzino.com
    Pictures for publication free of charge:
    Marcus Tollbom +46 (0) 70 190 03 12, [email protected]
    Erik Penser Bank Aktiebolag, +46 (0) 8 463 83 00, email: [email protected]
    Zinzino AB (publ) is obliged to publish this information in compliance with current EU regulations governing market abuse.
  • The information was provided by the above contact person for publication at 13:00 the 3rd of June 2021.

Analysis of Scandinavian ChemoTech AB published by Erik Penser Bank now available in English

Retrieved on: 
Friday, May 14, 2021

b"STOCKHOLM, May 14, 2021 /PRNewswire/ -- In accordance with the newsletter that was published the 5th of January 2021, Erik Penser Bank has now begun the implementation of a number of commissioned analyses, the first of which has been published and is available on ChemoTech's website in English:\n"

Key Points: 
  • b"STOCKHOLM, May 14, 2021 /PRNewswire/ -- In accordance with the newsletter that was published the 5th of January 2021, Erik Penser Bank has now begun the implementation of a number of commissioned analyses, the first of which has been published and is available on ChemoTech's website in English:\n"

OncoZenge secures approximately SEK 70 million in financing ahead of spin-off and separate listing

Retrieved on: 
Monday, November 16, 2020

The capital requirement to finance the Phase 3 study, expected to begin in early 2022, and the Company's continuing operations is approximately SEK 60 million.

Key Points: 
  • The capital requirement to finance the Phase 3 study, expected to begin in early 2022, and the Company's continuing operations is approximately SEK 60 million.
  • To secure its initial capital requirements, OncoZenge has received binding commitments for a directed issue of approximately SEK 10 million ("Directed Issue").
  • Based on the subscription price in the Directed Issue, the value of OncoZenge before the Directed Issue is approximately SEK 50 million, resulting in a dilution of approximately 16.7 percent from the Directed Issue.
  • Erik Penser Bank is serving as financial advisor and Gernandt & Danielsson Advokatbyr is serving as legal advisor to Moberg Pharma and OncoZenge in connection with the distribution, financing and listing of OncoZenge.

NFL Hall of Famer Willie Lanier Launches Initiative to Build New Football Fields at Historically Black Colleges and Universities (HBCUs)

Retrieved on: 
Tuesday, October 20, 2020

RICHMOND, Va., Oct. 20, 2020 /PRNewswire/ -- Willie Lanier, NFL Hall of Famer and former Kansas City Chiefs great is announcing an initiative to install state-of-the-art playing surfaces at nearly three-dozen Historically Black College Universities (HBCUs) football stadiums.

Key Points: 
  • RICHMOND, Va., Oct. 20, 2020 /PRNewswire/ -- Willie Lanier, NFL Hall of Famer and former Kansas City Chiefs great is announcing an initiative to install state-of-the-art playing surfaces at nearly three-dozen Historically Black College Universities (HBCUs) football stadiums.
  • "I'm excited about this project and I am confident we will get the support," said Lanier.
  • With more than five decades of charitable service, Lanier hopes building new fields at HBCUs will be his lasting legacy to the game of football and to America's Black colleges.
  • "With these fields, I hope to leave a bigger footprint on the game of football -- leveling the playing field for the nation's Black colleges by replacing their old fields with new ones," Lanier emphasizes.

Aquis Stock Exchange: Approval of Corporate Advisers

Retrieved on: 
Monday, September 14, 2020

Dissemination of a Regulatory Announcement, transmitted by EQS Group.

Key Points: 

Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
AQSE would like to announce Panmure Gordon's approval as an AQSE Corporate Adviser.
Approval is effective as of 02 September.

INVISIO Appoints Market Maker

Retrieved on: 
Monday, April 1, 2019

STOCKHOLM, April 1, 2019 /PRNewswire/ --INVISIO has today entered into an agreement with Erik Penser Bank AB that Erik Penser Bank shall act as market maker in the company's share.

Key Points: 
  • STOCKHOLM, April 1, 2019 /PRNewswire/ --INVISIO has today entered into an agreement with Erik Penser Bank AB that Erik Penser Bank shall act as market maker in the company's share.
  • In short, the agreement means that the market maker places bid and ask prices for INVISIO's share and ensures a low spread between buying and selling prices.
  • This information is information that INVISIO Communications AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation.
  • INVISIO develops and sells advanced communication systems with hearing protection that enable professionals in noisy and mission critical environments to communicate and operate effectively.

INVISIO Appoints Market Maker

Retrieved on: 
Monday, April 1, 2019

STOCKHOLM, April 1, 2019 /PRNewswire/ --INVISIO has today entered into an agreement with Erik Penser Bank AB that Erik Penser Bank shall act as market maker in the company's share.

Key Points: 
  • STOCKHOLM, April 1, 2019 /PRNewswire/ --INVISIO has today entered into an agreement with Erik Penser Bank AB that Erik Penser Bank shall act as market maker in the company's share.
  • In short, the agreement means that the market maker places bid and ask prices for INVISIO's share and ensures a low spread between buying and selling prices.
  • This information is information that INVISIO Communications AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation.
  • INVISIO develops and sells advanced communication systems with hearing protection that enable professionals in noisy and mission critical environments to communicate and operate effectively.